CF Industries CapEx decreased by 1.3% to $223.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 68.9%, from $132.00M to $223.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 16.6% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.00M | $201.00M | $132.00M | $63.00M | $66.00M | $190.00M | $134.00M | $69.00M | $95.00M | $147.00M | $188.00M | $98.00M | $84.00M | $139.00M | $197.00M | $132.00M | $245.00M | $347.00M | $226.00M | $223.00M |
| QoQ Change | — | +82.7% | -34.3% | -52.3% | +4.8% | +187.9% | -29.5% | -48.5% | +37.7% | +54.7% | +27.9% | -47.9% | -14.3% | +65.5% | +41.7% | -33.0% | +85.6% | +41.6% | -34.9% | -1.3% |
| YoY Change | — | — | — | — | -40.0% | -5.5% | +1.5% | +9.5% | +43.9% | -22.6% | +40.3% | +42.0% | -11.6% | -5.4% | +4.8% | +34.7% | +191.7% | +149.6% | +14.7% | +68.9% |